Results 101 to 110 of about 5,221 (170)

Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials.

JAMA Netw Open
Walter M, Zu Eulenburg C, Damyanova A, Schmid K, Schwienbacher I, Papanastasiou E, Maiboe K, Arvastson L, Strote C, Gehrlach D, Eriksson H.   +10 more
europepmc   +1 more source

The Effect of Intraoperative Infusion of Different Doses of Esketamine on the Quality of Recovery in Elderly Patients Undergoing Knee Arthroplasty. [PDF]

Drug Des Devel Ther
Fang C, Hu Z, Lv G, Fan X, Zhang X, Li W, Tian T, Yuan Y, Wang J, Chen X.   +9 more
europepmc   +1 more source

Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study". [PDF]

Ther Adv Psychopharmacol
europepmc   +1 more source

Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science. [PDF]

Clin Transl Sci
van Hoogdalem MW, Fu DJ, Drevets WC, Zannikos PN.   +3 more
europepmc   +1 more source

Esketamine ameliorates depression-like behavior in mice via modulation of the NRG1-ErbB4 pathway. [PDF]

Front Psychiatry
Yu H, Zhu Y, Wang J, He Y, Li H, Li S, Wang N, Chen N, Chen J, Song H, Zhang M, Wang W.   +11 more
europepmc   +1 more source

Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data. [PDF]

Transl Psychiatry
Liu TH, Shen HS, Wu JY, Huang PY, Shih YJ, Lai CC.   +5 more
europepmc   +1 more source

Repeated intranasal esketamine augmentation in treatment-resistant obsessive-compulsive disorder with comorbid major depressive disorder: a prospective case series. [PDF]

BMC Psychiatry
López-Rodríguez S, Segalàs C, Real E, Urretavizcaya M, Bertolín S, Menchón JM, Del Pino Alonso.   +6 more
europepmc   +1 more source

Effects of Intravenous Esketamine or Magnesium Sulfate on Early Postoperative Negative Emotions and Pain in Patients Undergoing Endoscopic Sinus Surgery: A Randomized Controlled Trial. [PDF]

Ther Clin Risk Manag
Wang L, Zhou J, Liu Q, Qian K, Wang L, Xie C.   +5 more
europepmc   +1 more source

Cost-effectiveness of esketamine versus alternative treatment strategies for treatment-resistant depression in Hong Kong: A multi-armed modeling study. [PDF]

PLoS Med
Li Y, Chan VKY, Jit M, Cheng FWT, Yiu HHE, Bishai DM, Craig D, Chan EWY, Chan SSM, Li X.   +9 more
europepmc   +1 more source

Median effective dose (ED₅₀) of esketamine combined with different doses of propofol for children to inhibit the response to gastroscope insertion: a prospective dose-response clinical study. [PDF]

BMC Anesthesiol
Niu K, Li L, Wu X, Xia N, Zhu J.
europepmc   +1 more source